Kodai Capital Management LP bought a new stake in Schrodinger, Inc. (NASDAQ:SDGR - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 153,313 shares of the company's stock, valued at approximately $3,026,000. Kodai Capital Management LP owned approximately 0.21% of Schrodinger at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in SDGR. American Century Companies Inc. bought a new stake in Schrodinger during the 1st quarter worth approximately $19,787,000. Stephens Investment Management Group LLC increased its holdings in Schrodinger by 22.5% during the 1st quarter. Stephens Investment Management Group LLC now owns 1,969,941 shares of the company's stock worth $38,887,000 after purchasing an additional 362,285 shares in the last quarter. Millennium Management LLC increased its holdings in Schrodinger by 42.3% during the 4th quarter. Millennium Management LLC now owns 761,653 shares of the company's stock worth $14,692,000 after purchasing an additional 226,536 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Schrodinger during the 1st quarter worth approximately $4,027,000. Finally, Nuveen LLC bought a new stake in Schrodinger during the 1st quarter worth approximately $2,872,000. 79.05% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of analysts have commented on the company. KeyCorp decreased their price objective on Schrodinger from $32.00 to $30.00 and set an "overweight" rating for the company in a report on Monday, July 14th. Barclays assumed coverage on Schrodinger in a report on Thursday, August 14th. They issued an "overweight" rating and a $25.00 target price for the company. Wall Street Zen lowered Schrodinger from a "hold" rating to a "sell" rating in a report on Saturday. Morgan Stanley reduced their target price on Schrodinger from $28.00 to $19.00 and set an "equal weight" rating for the company in a report on Monday, August 18th. Finally, Citigroup lowered Schrodinger from a "buy" rating to a "neutral" rating and reduced their target price for the company from $35.00 to $20.00 in a report on Friday, August 15th. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $27.83.
Check Out Our Latest Report on Schrodinger
Schrodinger Stock Performance
NASDAQ SDGR traded down $0.25 on Monday, hitting $19.51. 703,990 shares of the stock traded hands, compared to its average volume of 1,391,400. The business's fifty day moving average is $20.52 and its two-hundred day moving average is $21.89. Schrodinger, Inc. has a 12 month low of $16.60 and a 12 month high of $28.47. The firm has a market capitalization of $1.44 billion, a price-to-earnings ratio of -7.87 and a beta of 1.79.
Schrodinger (NASDAQ:SDGR - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported ($0.59) earnings per share for the quarter, beating the consensus estimate of ($0.83) by $0.24. Schrodinger had a negative return on equity of 45.70% and a negative net margin of 76.22%.The business had revenue of $54.76 million during the quarter, compared to analyst estimates of $52.03 million. During the same period in the prior year, the company earned ($0.66) earnings per share. Schrodinger's revenue was up 15.7% compared to the same quarter last year. Analysts expect that Schrodinger, Inc. will post -2.37 EPS for the current fiscal year.
About Schrodinger
(
Free Report)
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
Further Reading

Before you consider Schrodinger, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrodinger wasn't on the list.
While Schrodinger currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.